Join to View Full Profile
3601 4th StLubbock, TX 79430
Phone+1 806-743-1000
Dr. Danpanichkul is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a first-year internal medicine resident at Texas Tech University Health Sciences Center in Lubbock, Texas. Originally from Thailand, I graduated from Chiang Mai University in 2022. My research focuses on gastroenterology and hepatology, with a special interest in alcohol-associated liver disease and liver cancer. I have experience conducting large epidemiologic studies and have authored multiple articles, including in leading journals such as Hepatology, Gut, Clinical Gastroenterology and Hepatology, American Journal of Gastroenterology, Clinical and Molecular Hepatology, Journal of Hepatology, and JHEP Reports, serving as first author
Education & Training
Texas Tech University Health Sciences Center at LubbockResidency, Internal Medicine, 2024 - 2027
Chiang Mai UniversityClass of 2022
Publications & Presentations
PubMed
- 1 citationsMortality of Gastrointestinal Cancers Attributable to Smoking, Alcohol, and Metabolic Risk Factors, and its Association With Socioeconomic Development Status 2000-2021.Pojsakorn Danpanichkul, Kanokphong Suparan, Yanfang Pang, Thanida Auttapracha, Ethan Kai Jun Tham
The American Journal of Medicine. 2025-05-01 - 15 citationsLiver cancer in 2021: Global Burden of Disease study.En Ying Tan, Pojsakorn Danpanichkul, Jie Ning Yong, Zhenning Yu, Darren Jun Hao Tan
Journal of Hepatology. 2025-05-01 - Angiotensin-Converting Enzyme Inhibitor-Drug Induced Liver Injury: Clinical Features and Diagnostic Features - A Systematic Review of Current Reported Cases.Thanathip Suenghataiphorn, Narisara Tribuddharat, Pojsakorn Danpanichkul, Narathorn Kulthamrongsri
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi. 2025-04-25
Press Mentions
H1-Antihistamine Identified as Key Component in Acute Urticaria Treatment, Intravenous sgAH Preferred as Initial OptionFebruary 6th, 2024
‘Fatty liver’ may be more common than previously thoughtMarch 5th, 2025
HCPLiveFebruary 25th, 2025- Join now to see all
Professional Memberships
- Member
- Member
- American Association for the Study of Liver DiseasesMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
